Open AccessPost-COVID syndrome: pulmonary complications
Author(s) -
Dorina Esendağlı,
Aydın Yılmaz,
Müşerref Şule Akçay,
Tevfik Özlü
Publication year - 2021
Publication title -
turkish journal of medical sciences
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-2106-238
Subject(s) - medicine , ards , covid-19 , intensive care medicine , diabetes mellitus , pulmonary fibrosis , disease , mechanical ventilation , lung , infectious disease (medical specialty) , endocrinology
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people worlwide and caused a pandemic that is still ongoing. The virus can cause a disease named as COVID-19, which is composed of multi systemic manifestations with a pulmonary system predominance. As the time passes, we are dealing more and more with a wide variety of effects and complications of the disease in survivors as far as with concerns about the clinical outcome and the timeline of symptoms in different patients. Since the lungs are the most involved organs and the post-COVID prolonged and persistent effects are mainly related to the pulmonary system, it is crucial to define and predict the outcome and to determine the individuals that can progress to fibrosis and loss of function of lungs. This review summarizes the current literature regarding the pulmonary complications in post-COVID syndrome and the management of these conditions.